Northern Delaware Is Growing Its Own Life Sciences Industry Rather Than Waiting For Overflow From Philly
“I’m always surprised at how separate the Wilmington area is from the city and the Pennsylvania suburbs,” Buccini/Pollin Group co-President Chris Buccini told
Bisnow. “Especially considering how many people live in Philly and work in Delaware and vice versa, Wilmington always is considered very separate … It’s the funniest thing.”
What Northern Delaware does have is two reliable sources of talent and startup companies: The University of Delaware and DuPont, the leftover company from the 2017 merger of DuPont and Dow Chemical and subsequent spinoff into three separate entities. Just as the University of Pennsylvania and Children’s Hospital of Philadelphia birthed the cell and gene therapy boom, Delaware’s own growth in life sciences resembles its major pillars.
Delaware Innovation Space offers financial option in accelerator program delawarebusinessnow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from delawarebusinessnow.com Daily Mail and Mail on Sunday newspapers.
Delaware-based NiKang Therapeutics Inc. completed an oversubscribed $200 million series C financing. Last year, the company received $50 million in series B financing. “We are thrilled to have such an outstanding group of investors as our shareholders” said Zhenhai Gao, CEO of NiKang. “Their
Delaware-based NiKang Therapeutics Inc. completed an oversubscribed $200 million series C financing. Last year, the company received $50 million in series B financing. “We are thrilled to have such an outstanding group of investors as our shareholders” said Zhenhai Gao, CEO of NiKang. “Their